메뉴 건너뛰기




Volumn 157, Issue 5, 2000, Pages 1467-1472

Chromogenic in situ hybridization: A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

Author keywords

[No Author keywords available]

Indexed keywords

DIAMINOBENZIDINE; DIGOXIGENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCEIN; FLUORESCEIN PEROXIDASE; ONCOPROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

EID: 0033694650     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64785-2     Document Type: Article
Times cited : (353)

References (16)
  • 2
    • 0032844121 scopus 로고    scopus 로고
    • Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group
    • (1999) Semin Oncol , vol.6 , pp. 71-77
    • Shak, S.1
  • 6
    • 0032827938 scopus 로고    scopus 로고
    • The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancer
    • (1999) Semin Oncol , vol.26 , pp. 108-116
    • Mitchell, M.S.1    Press, M.F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.